Markets › India › NSE › EMCURE

Emcure Pharmaceuticals Ltd

NSE:EMCUREHealthcareNSE:CNX500NSE:NIFTY500_EW

₹1,766.60−2.97%At closeAt close · Mon 19 Oct · ≈ AED 68.26 · Market cap $3.64B · Next earnings Tue 3 Nov

Ratio	FY2020	FY2022	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	28.7%	32.5%	32.5%	31.9%	0.4%	38.9%	—	—
Operating margin	14.6%	—	15.0%	13.1%	13.9%	14.9%	14.9%	+0.0 pts
Net margin	6.5%	9.0%	9.0%	7.6%	8.7%	10.0%	10.0%	+0.0 pts
EBITDA margin	19.9%	19.4%	19.4%	17.9%	19.2%	20.1%	—	—
Return on equity	17.3%	—	21.3%	16.9%	15.3%	18.7%	18.6%	−0.1 pts
Return on assets	5.6%	7.9%	7.9%	6.3%	8.3%	9.6%	9.6%	+0.0 pts
Return on capital employed	24.5%	—	23.9%	18.4%	19.5%	24.1%	—	—
Debt / equity	1.1×	—	0.9×	0.8×	0.2×	0.3×	0.3×	−0.5%
Debt / assets	35.2%	34.4%	34.4%	29.3%	12.4%	15.8%	—	—
Interest coverage	4.9×	0.0×	4.3×	3.6×	7.7×	9.6×	—	—
Current ratio	1.1×	—	1.3×	1.3×	1.7×	1.4×	1.4×	+0.0%
Quick ratio	0.6×	—	0.8×	0.8×	1.0×	0.8×	—	—
Cash ratio	0.1×	—	0.1×	0.1×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	0.9×	0.9×	0.9×	0.8×	0.9×	1.0×	—	—
Inventory turnover	2.8×	—	2.7×	2.8×	0.0×	2.3×	—	—
Receivables turnover	4.0×	—	3.4×	3.4×	3.8×	3.6×	—	—
Dividend payout	4.6%	—	8.3%	12.5%	0.0%	6.2%	—	—